Pharma-Bio Serv Inc. (OTCMKTS:PBSV) Short Interest Up 50.0% in May

Pharma-Bio Serv Inc. (OTCMKTS:PBSV) was the recipient of a significant growth in short interest during the month of May. As of May 31st, there was short interest totalling 300 shares, a growth of 50.0% from the May 15th total of 200 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average trading volume of 3,600 shares, the days-to-cover ratio is currently 0.1 days.

Pharma-Bio Serv Stock Performance

Pharma-Bio Serv stock opened at $0.49 on Wednesday. The company has a 50-day moving average price of $0.47 and a 200 day moving average price of $0.51. Pharma-Bio Serv has a 12-month low of $0.31 and a 12-month high of $0.67. The stock has a market cap of $11.24 million, a P/E ratio of -49.00 and a beta of 0.68.

Pharma-Bio Serv (OTCMKTS:PBSV) last issued its quarterly earnings results on Monday, March 17th. The company reported $0.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.02 by $0.35. The company had revenue of $2.47 million for the quarter, compared to analyst estimates of $2.70 million. Pharma-Bio Serv had a negative net margin of 1.96% and a negative return on equity of 1.44%. As a group, analysts forecast that Pharma-Bio Serv will post 0.11 EPS for the current year.

About Pharma-Bio Serv

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.